Salvia BioElectronics raised €53M in a Series B round in May 2025. The company is based in Eindhoven, Netherlands. Investors in the round: Brabant Development Agency (BOM), Dolby Family Ventures, EIC Fund and 6 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
